Financial Performance - Net profit attributable to shareholders for the first nine months of 2024 was CNY 25,191,142.54, representing a significant increase of 58.60% from CNY 15,883,806.45 in the same period of 2023[3] - Operating income for Q3 2024 was CNY 43,708,016.93, reflecting a growth of 23.77% compared to CNY 35,313,107.48 in Q3 2023[3] - Operating profit rose by 60.96% to ¥28,490,216.05, driven by new product development and improved material costs[5] - Total profit increased by 61.65% to ¥28,248,389.82, reflecting the growth in operating profit[5] - The company reported a net profit of CNY 80,354,828.51, up from CNY 69,921,409.41, reflecting a growth of approximately 14.5%[20] - The total comprehensive income for the period reached ¥25,344,151.57, compared to ¥15,681,228.34 in the previous period, indicating a significant increase[27] Cash Flow - The net cash flow from operating activities for the first nine months of 2024 was CNY 34,647,406.66, a substantial increase of 111.36% from CNY 16,392,269.76 in the same period last year[3] - Cash flow from operating activities reached ¥34,647,406.66, up 111.36% due to higher cash receipts from sales[6] - Cash flow from investing activities was -¥10,367,933.92, an increase of 80.77% primarily due to reduced cash outflow from purchasing financial products[6] - Cash flow from financing activities amounted to -¥5,385,663.95, a 51.76% increase due to net bank borrowings rising by ¥10,000,000[6] - The cash flow from financing activities showed a net outflow of ¥5,265,663.95, an improvement from the previous outflow of ¥11,060,642.40[30] - The net increase in cash and cash equivalents for the period was ¥18,119,694.36, contrasting with a decrease of ¥48,920,106.72 in the prior year, highlighting improved liquidity[30] Assets and Liabilities - Total assets as of September 30, 2024, reached CNY 298,849,074.90, an increase of 10.50% compared to CNY 270,443,958.93 at the end of 2023[3] - The company's total liabilities to assets ratio (consolidated) increased to 14.70% from 9.60% year-on-year[3] - Current liabilities rose to CNY 33,960,330.93, compared to CNY 25,680,383.85, marking an increase of about 32.5%[19] - The total liabilities increased to CNY 43,943,752.75 from CNY 25,972,055.88, indicating a growth of approximately 69%[20] - Owner's equity increased to CNY 254,905,322.15 from CNY 244,471,903.05, showing a rise of about 4.9%[20] Investments and Projects - As of September 30, 2024, the company has invested 28% of the planned amount in the production base expansion project[15] - The research and development center construction project has seen 25% of the planned investment utilized[15] - The total amount of raised funds is approximately ¥104.58 million, with a cumulative investment of ¥56.50 million[16] - Cash flow projects and oversubscription projects have been fully utilized, with significant investments expected in the fourth quarter[15] Shareholder Information - The total number of shares outstanding is 73,737,616, with major shareholders holding 71.39% of the shares[9] - The company has initiated a new equity incentive plan, which is currently in the registration process[13] Credit and Impairment - Credit impairment losses surged by 1,524.32% to -¥911,305.87, attributed to increased accounts receivable and higher bad debt provisions[5] - The company experienced a credit impairment loss of ¥911,305.87 in 2024, compared to a loss of ¥56,103.86 in 2023, indicating a significant increase in credit risk[25] Other Financial Metrics - Basic earnings per share for Q3 2024 increased to CNY 0.14, a 100.00% rise from CNY 0.07 in Q3 2023[3] - Basic earnings per share increased to ¥0.34 in 2024 from ¥0.22 in 2023, reflecting a growth of about 54.5%[25] - Research and development expenses remained stable at ¥6,149,541.34 in 2024, slightly down from ¥6,369,076.43 in 2023, showing a decrease of about 3.5%[24] - The company reported an investment income of ¥862,809.19 for the first nine months of 2024, compared to ¥764,782.52 in 2023, which is an increase of approximately 12.9%[24]
派特尔(836871) - 2024 Q3 - 季度财报